Table 3:

Severe emergency department visits* and admissions to hospital, by cannabis-related and non–cannabis-related visit, 2003 and 2017

Visit type20032017Increase 2003–2017§ (95% CI)
No. of severe visitsSevere visits, % (95% CI)Rate ratio (95% CI)No. of severe visitsSevere visits, % (95% CI)Rate ratio (95% CI)
Visits coded resuscitation, emergent or urgent
Cannabis related65265.7 (62.8–68.7)2.1 (2.0–2.2)460688.2 (87.3–89.0)1.52 (1.50–1.53)1.3 (1.3–1.4)
Non–cannabis related279 25331.0 (30.9–31.1)583 79958.1 (58.0–58.2)1.9 (1.9–1.9)
Visit type20032017Increase 2003–2017§ (95% CI)
No. of transfersTransfers, % (95% CI)Rate ratio (95% CI)No. of transfersTransfers, % (95% CI)Rate ratio (95% CI)
ED visits with hospital admission
Cannabis related899.0 (7.2–10.8)1.8 (1.5–2.2)99519.0 (18.0–20.1)3.3 (3.1–3.5)2.1 (1.7–2.6)
Non–cannabis related45 1725.0 (5.0–5.1)58 0225.8 (5.7–5.8)1.2 (1.1–1.2)
  • Note: CI = confidence interval, ED = emergency department.

  • * A severe Canadian Triage and Acuity Scale (CTAS) score includes visits coded as urgent, emergent or resuscitation.

  • 992 cannabis-related and 900 256 non–cannabis-related emergency department visits in 2003; 5224 cannabis-related and 1 004 909 non–cannabis-related emergency department visits in 2017.

  • Rate ratio = (% of cannabis-related visits)/(% of non–cannabis-related visits).

  • § Increase 2003–2017 = (% of visits in 2017)/(% of visits in 2003).

  • Severe visits, which was the CTAS score collapsed to visits coded “resuscitation, emergent or urgent,” had less than 1% missing data.